Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence

Nature Immunology

Volumn 9, Issue 10, 2008, Pages 1189-1197

  Gan, Huixian ^a   Lee, Jinhee ^b   Ren, Fucheng ^a   Chen, Minjian ^a   Kornfeld, Hardy ^b   Remold, Heinz G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN 1; PHOSPHATIDYLSERINE; PHOSPHOLIPID BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL SURFACE; CONTROLLED STUDY; EXPOSURE; GENE SILENCING; IMMUNOBLOTTING; IN VITRO STUDY; LUNG INFECTION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANNEXINS; APOPTOSIS; HUMANS; IMMUNOBLOTTING; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; PLASMINOGEN ACTIVATOR INHIBITOR 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBERCULOSIS; VIRULENCE;

EID: 52549123569     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1654     Document Type: Article

References (59)

1. Leemans, J.C. et al. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166, 4604-4611 (2001).
2. Vergne, I., Chua, J., Singh, S.B. & Deretic, V. Cell biology of Mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 20, 367-394 (2004).
3. Keane, J. et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65, 298-304 (1997).
4. Riendeau, C.J. & Kornfeld, H. THP-1 cell apoptosis in response to Mycoloacterial infection. Infect. Immun. 71, 254-259 (2003).
5. Keane, J., Remold, H.G. & Kornfeld, H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 164, 2016-2020 (2000).
6. Spira, A. et al. Apoptosisgenes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: A pivotal role for tumor necrosis factor. Am. J. Respir. Cell Mol. Biol. 29, 545-551 (2003).
7. Sly, L.M., Hingley-Wilson, S.M., Reiner, N.E. & McMaster, W.R. Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1. J. Immunol. 170, 430-437 (2003).
8. Balcewicz-Sablinska, M.K., Keane, J., Kornfeld, H. & Remold, H.G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J. Immunol. 161, 2636-2641 (1998).
9. Oddo, M. et al. Fas ligand-induced apoptosis of infected human alveolar macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160, 5448-5454 (1998).
10. Schaible, U.E. et al. Apoptosis facilitates antigen presentation to T lymphocytes through MHC-1 and CD1 in tuberculosis. Nat. Med. 9, 1039-1046 (2003).
11. Winau, F. et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 24, 105-117 (2006).
12. Park, J.S., Tamayo, M.H., Gonzalez-Juarrero, M., Orme, I.M. & Ordway, D.J. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J. Leukoc. Biol. 79, 80-86 (2006).
13. Chen, M., Gan, H. & Remold, H.G. A mechanism of virulence: Virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 176, 3707-3716 (2006).
14. Lee, J., Remold, H.G., Ieong, M.H. & Kornfeld, H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J. Immunol. 176, 4267-4274 (2006).
15. Robinson, N.A., Lapic, S., Welter, J.F & Eckert, R.L. S100A11, S100A10, annexin 1, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J. Biol. Chem. 272, 12035-12046 (1997).
16. Fadok, V.A., Bratton, D.L. & Henson, P.M. Phagocyte receptors for apoptotic cells: Recognition, uptake, and consequences. J. Clin. Invest. 108, 957-962 (2001).
17. Fratazzi, C., Arbeit, R.D., Carini, C. & Remold, H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents mycobacteria from spreading and induces mycobacterial growth inhibition by freshly added, uninfected macrophages. J. Immunol. 158, 4320-4327 (1997).
18. Pan, H. et al. lpr1 gene mediates innate immunity to tuberculosis. Nature 434, 767-772 (2005).
19. 2+-dependent phospholipid binding and phosphorylation of lipocortin I. J. Biol. Chem. 262, 6931-6937 (1987).
20. 2+ sensitivity by tissue transglutaminase. Biochem. Biophys. Res. Commun. 163 944-951 (1989).
21. Jensen, P.J., Wu, Q., Janowitz, P., Ando, Y. & Schechter, N.M. Plasminogen activator inhibitor type 2: An intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp. Cell Res. 217, 65-71 (1995).
22. Traverso, V., Morris, J.F., Flowers, R.J. & Buckingham, J. Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cell cytoplasm. J. Cell Sci. 111, 1405-1418 (1998).
23. 2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6, 449-461 (2005).
24. Kaufmann, S.H. & Earnshaw, W.C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49 (2000).
25. 2+-induced cross-linking of membrane proteins in intact human erythrocytes. Biochemistry 17, 2598-2604 (1978).
26. Ando, Y., Imamura, S., Owada, M.K. & Kannagi, R. Calcium-induced intracellular cross-linking of lipocortin I by tissue transglutaminase in A431 cells. Augmentation by membrane phospholipids. J. Biol. Chem. 266, 1101-1108 (1991).
27. Oling, F., Bergsma-Schutter, W. & Brisson, A. Trimers, dimers of trimers, and trimers of trimers are common building blocks of annexin a5 two-dimensional crystals. J. Struct. Biol. 133, 55-63 (2001).
28. Dickinson, J.L., Bates, E.J., Ferrante, A. & Antalis, T. M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270, 27894-27904 (1995).
29. Gan, H., Newman, G.W. & Remold, H.G. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J. Immunol. 155, 1304-1315 (1995).
30. Costelloe, E.O., Stacey, K.J., Antalis, T.M. & Hume, D.A. Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J. Leukoc. Biol. 66, 172-182 (1999).
31. Schwartz, B.S. & Bradshaw, J. D. Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. J. Biol. Chem. 267, 7089-7094 (1992).
32. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K. & Serhan, C.N. Lipid mediator class switching during acute inflammation signals in resolution. Nat. Immunol. 2, 612-619 (2001).
33. Bafica, A. et al. Host control of Mycobacterium tuberculosis is regulated by lipoxygenase-dependent lipoxin production. J. Clin. Invest. 115, 1601-1606 (2005).
34. Oliani, S.M., Paul-Clark, M.J., Christian, H.C., Flower, R.J. & Perretti, M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158, 603-615 (2001).
35. Jensen, P.H. et al. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking. J. Biol. Chem. 269, 15394-15398 (1994).
36. Jensen, P.H., Lorand, L., Elobesen, P. & Gliemann, J. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures. Eur. J. Biochem. 214, 141-146 (1993).
37. Dickinson, J.L., Norris, B.J., Jensen, P.H. & Antalis, T.M. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis. Cell Death Differ. 5, 163-171 (1998).
38. Silverman, G.A. et al. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cell. Mol. Life Sci. 61, 301-325 (2004).
39. Barber, G.N. Host defense, viruses and apoptosis. Cell Death Differ. 8, 113-126 (2001).
40. Keane, J., Shurtleff, B. & Kornfeld, H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-γ independent manner. Tuberculosis (Edinb.) 82, 55-61 (2002).
41. Ciaramella, A. et al. Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycoloacterial infection. J. Infect. Dis. 190, 1167-1176 (2004).
42. Lopez, M. et al. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol. 170, 2409-2416 (2003).
43. Worku, S. & Hoft, D.F. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect. Immun. 71, 1763-1773 (2003).
44. Wolf, A.J. et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179, 2509-2519 (2007).
45. Li, M. et al. An essential role of the NF-κB/Toll like receptor pathways In induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166, 7128-7138 (2001).
46. Arur, S. et al. Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4, 587-598 (2003).
47. Knight, R.L., Hand, D., Piacentini, M. & Griffin, M. Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver; its relationship to apoptosis. Eur. J. Cell Biol. 60, 210-216 (1993).
48. Steinert, P.M. & Marekov, L.N. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J. Biol. Chem. 270, 17702-17711 (1995).
49. Levitt, M.L., Gazdar, A.F, Oie, H.K., Schuller, H. & Thacher, S.M. Cross-linked envelope-related markers for squamous differentiation in human lung cancer cell lines. Cancer Res. 50, 120-128 (1990).
50. Grenard, P. et al. Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J. Hepatol. 35, 367-375 (2001).
51. Lathem, W.W., Price, P.A., Miller, V. & Goldman, W. E. A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 315, 509-513 (2007).
52. Kruithof, E.K., Baker, M.S. & Bunn, C.L. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86, 4007-4024 (1995).
53. von, H.G., Liljestrom, P., Mikus, P., Andersson, H. & Ny, T. The efficiency of the uncleaved secretion signal in the plasminogen activator inhibitor type 2 protein can be enhanced by point mutations that increase its hydrophobicity. J. Biol. Chem. 266, 15240-15243 (1991).
54. Kruithof, E.K., Vassalli, J.D., Schleuning, W.D., Mattaliano, R.J. & Bachmann, F. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J. Biol. Chem. 261, 11207-11213 (1986).
55. Vassalli, J.D., Dayer, J.M., Wohlwend, A. & Belin, D. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J. Exp. Med. 159, 1653-1668 (1984).
56. Chan, F. K. et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 278, 51613-51621 (2003).
57. Kroemer, G., Dallaporta, B. & Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60, 619-642 (1998).
58. Dougherty, K.M. et al. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc. Natl. Acad. Sci. 96, 686-691 (1999).
59. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63 (1983).